I start by thanking my hon. Friend the Member for Ribble Valley (Mr. Evans) for allowing me to make a brief contribution to the debate.I would like to express the thanks of the whole House for the life and work of Father Angelo d’Agostino, a noted AIDS campaigner who died in Kenya last week and whom the Secretary of State has met. He was famous throughout the world for his work in founding the Nyumbani orphanage in Kitui, southern Kenya, and for his work in distributing anti-retroviral drugs in the slums of Nairobi. He will be greatly missed, but his work will continue.Echoing the comments of the hon. Member for Walthamstow (Mr. Gerrard), I thank the Secretary of State for his personal commitment to the battle against AIDS. I would like to thank him not just for the achievement of Gleneagles and the universal access target, not just for persuading the UN to adopt interim country-level targets—the Secretary of State knows that I campaigned for them—but for putting his money where his mouth is. The fact is that DFID is the second biggest donor internationally in the battle against AIDS. By doing that, he shows—and we show as a country—that we recognise that without progress in the battle against AIDS, there can be no progress in development at all in Africa.I would be grateful if the Secretary of State dealt with three concerns about moves towards universal access. First, I have researched some figures that seem to indicate that the cost of distribution of anti-retroviral drugs is up to five times higher through the global fund as compared with the distribution through PEPFAR—the President’s Emergency Plan for AIDS Relief. That is connected to the fact that PEPFAR is quite happy to distribute anti-retrovirals directly to non-governmental organisations, whereas the global fund tends to prefer to distribute through host country Governments. That is obviously a great concern and the effectiveness of the global fund will be incredibly important in this battle.My second concern is the continued lack of availability of paediatric anti-retroviral drugs, which I know that the Secretary of State has looked into. My third concern is how we are going to meet the targets for universal access in conflict and post-conflict zones—in countries such as the Democratic Republic of the Congo, where there is little or no health infrastructure. I am not sure that we have a strategy for determining whether we can achieve that and, if so, how best to do it. It is a very important consideration. I finish by urging the Secretary of State to show the same commitment to achieving the goals of Gleneagles as he showed in securing them. I am sure that he will show that commitment. The hopes of a whole generation of Africans and, indeed, the hopes of the entire House rest on his personal commitment.